Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Evaluation of quality of life in patients with oral cancer after mandibular resection: Comparing no reconstruction, reconstruction with plate, and reconstruction with flap.

Davudov MM, Harirchi I, Arabkheradmand A, Garajei A, Mahmudzadeh H, Shirkhoda M, Motiee-Langroudi M, Mirzajani Z, Zebardast J, Montazeri A.

Medicine (Baltimore). 2019 Oct;98(41):e17431. doi: 10.1097/MD.0000000000017431.

2.

Factors Associated with Dual Practice in Surgery Specialists: Application of Multi-Level Analysis on National Registry Data.

Bayat M, Khalilnejad R, Akbari-Sari A, Harirchi I, Salehi Zalani G, Mirbahaeddin SE, Khodadost M, Jafari Pooyan E, Yaseri M, Shokri A.

Iran J Public Health. 2019 May;48(5):882-892.

3.

The NCCN Criterion "Young Age at Onset" Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population.

Ebrahimi E, Sellars E, Shirkoohi R, Harirchi I, Ghiasvand R, Mohebbi E, Zendehdel K, Akbari MR.

Cancer Prev Res (Phila). 2019 Nov;12(11):763-770. doi: 10.1158/1940-6207.CAPR-19-0056. Epub 2019 Aug 26.

PMID:
31451522
4.

The harsh effects of sanctions on Iranian health.

Danaei G, Harirchi I, Sajadi HS, Yahyaei F, Majdzadeh R.

Lancet. 2019 Aug 10;394(10197):468-469. doi: 10.1016/S0140-6736(19)31763-5. Epub 2019 Aug 8. No abstract available. Erratum in: Lancet. 2019 Sep 7;394(10201):830.

PMID:
31402025
5.

The impact of provider payment reforms and associated care delivery models on cost and quality in cancer care: A systematic literature review.

Nejati M, Razavi M, Harirchi I, Zendehdel K, Nejati P.

PLoS One. 2019 Apr 5;14(4):e0214382. doi: 10.1371/journal.pone.0214382. eCollection 2019.

6.

Factors influencing medical specialists' dual practice in the Islamic Republic of Iran.

Bayat M, Shokri A, Khodadost M, Fattahi H, Mirbahaeddin E, Harirchi I, Akbari-Sari A, Zalani GS, Khalilnezhad R.

East Mediterr Health J. 2018 Dec 9;24(9):877-887. doi: 10.26719/2018.24.9.877.

7.

Effect of dual practice on service delivery time by surgeons in the Islamic Republic of Iran: multi-level analysis of a national survey, 2016.

Bayat M, Shokri A, Khalilnezhad R, Mirbahaeddin E, Khodadost M, Fattahi H, Zalani GS, Harirchi I, Yaser M, Jaafaripooyan E, Akbari-Sari A.

East Mediterr Health J. 2018 Dec 9;24(9):866-876. doi: 10.26719/2018.24.9.866.

8.

Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.

Allameh A, Moazeni-Roodi A, Harirchi I, Ravanshad M, Motiee-Langroudi M, Garajei A, Hamidavi A, Mesbah-Namin SA.

Pathol Oncol Res. 2019 Oct;25(4):1535-1543. doi: 10.1007/s12253-018-0542-1. Epub 2018 Dec 3.

PMID:
30511108
9.

Extent and nature of dual practice engagement among Iran medical specialists.

Bayat M, Salehi Zalani G, Harirchi I, Shokri A, Mirbahaeddin E, Khalilnezhad R, Khodadost M, Yaseri M, Jaafaripooyan E, Akbari-Sari A.

Hum Resour Health. 2018 Nov 20;16(1):61. doi: 10.1186/s12960-018-0326-4.

10.

Reduction and elimination solutions of informal payment in Iran's health system.

Habibi Nodeh F, Jafari Pooyan I, Harirchi I, Arab M.

Med J Islam Repub Iran. 2017 Dec 28;31:139. doi: 10.14196/mjiri.31.139. eCollection 2017.

11.

Studies on the Contribution of Cox-2 Expression in the Progression of Oral Squamous Cell Carcinoma and H-Ras Activation.

Moazeni-Roodi A, Allameh A, Harirchi I, Motiee-Langroudi M, Garajei A.

Pathol Oncol Res. 2017 Apr;23(2):355-360. doi: 10.1007/s12253-016-0114-1. Epub 2016 Sep 15.

PMID:
27628320
12.

Comparative Evaluation of EGF in Oral Lichen Planus and Oral Squamous Cell Carcinoma.

Agha-Hosseini F, Mohebbian M, Sarookani MR, Harirchi I, Mirzaii-Dizgah I.

Acta Med Iran. 2015 Aug;53(8):471-5.

13.

Reconstruction of Midface and Orbital Wall Defects After Maxillectomy and Orbital Content Preservation With Titanium Mesh and Fascia Lata: 3-Year Follow-Up.

Motiee-Langroudi M, Harirchi I, Amali A, Jafari M.

J Oral Maxillofac Surg. 2015 Dec;73(12):2447.e1-5. doi: 10.1016/j.joms.2015.08.011. Epub 2015 Aug 28.

PMID:
26343761
14.

Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: a Pilot Study.

Sadighi S, Keyhani A, Harirchi I, Garajei A, Aghili M, Kazemian A, Motiee Langroudi M, Zendehdel K, Nikparto N.

Acta Med Iran. 2015;53(6):380-6.

15.

Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.

Agha-Hosseini F, Mirzaii-Dizgah I, Mahboobi N, Shirazian S, Harirchi I.

J Contemp Dent Pract. 2015 Feb 1;16(2):107-11.

PMID:
25906800
16.

Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?

Ghiasvand R, Adami HO, Harirchi I, Akrami R, Zendehdel K.

BMC Cancer. 2014 May 19;14:343. doi: 10.1186/1471-2407-14-343.

17.

Factors affecting professional delay in diagnosis and treatment of oral cancer in Iran.

Esmaelbeigi F, Hadji M, Harirchi I, Omranipour R, vand Rajabpour M, Zendehdel K.

Arch Iran Med. 2014 Apr;17(4):253-7. doi: 014174/AIM.007.

18.

Situation analysis of the National Comprehensive Cancer Control Program (2013) in the I. R. of Iran; assessment and recommendations based on the IAEA imPACT mission.

Rouhollahi MR, Mohagheghi MA, Mohammadrezai N, Ghiasvand R, Ghanbari Motlagh A, Harirchi I, Zendehdel K.

Arch Iran Med. 2014 Apr;17(4):222-31. doi: 014174/AIM.003.

19.

Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival.

Harirchi I, Kolahdoozan S, Hajizadeh S, Safari F, Sedighi Z, Nahvijou A, Mir MR, Mousavi SM, Zendehdel K.

Eur J Surg Oncol. 2014 Mar;40(3):352-7. doi: 10.1016/j.ejso.2013.10.011. Epub 2013 Oct 23.

PMID:
24238763
20.

Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran.

Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, Mir A, Lashkari M, Zendehdel K.

Dig Surg. 2013;30(4-6):331-6. doi: 10.1159/000354854. Epub 2013 Sep 17.

PMID:
24051550
21.

Childhood tongue squamous cell carcinoma.

Harirchi I, Hakimian S, Kiamoosavi S, Mahmoodzadeh H.

J Res Med Sci. 2012 May;17(5):495-7.

22.

Literacy and breast cancer prevention: a population-based study from Iran.

Harirchi I, Azary S, Montazeri A, Mousavi SM, Sedighi Z, Keshtmand G, Zarinkolah Z, Soltani SM.

Asian Pac J Cancer Prev. 2012;13(8):3927-30.

23.

Papillary thyroid carcinoma associated with parathyroid adenoma.

Mahmoodzadeh H, Harirchi I, Hassan Esfehani M, Alibakhshi A.

Acta Med Iran. 2012;50(5):353-4.

24.

Sexual function in breast cancer patients: a prospective study from Iran.

Harirchi I, Montazeri A, Zamani Bidokhti F, Mamishi N, Zendehdel K.

J Exp Clin Cancer Res. 2012 Mar 9;31:20. doi: 10.1186/1756-9966-31-20.

25.

Tubo-ovarian abscess in a virgin girl.

Ashrafganjooei T, Harirchi I, Iravanlo G.

Iran J Reprod Med. 2011 Summer;9(3):247-50.

26.

Factors associated with mortality in adult hospitalized burn patients in Tehran.

Zarei MR, Dianat S, Eslami V, Harirchi I, Boddouhi N, Zandieh A, Rasouli MR.

Ulus Travma Acil Cerrahi Derg. 2011 Jan;17(1):61-5.

27.

Twenty years of breast cancer in Iran: downstaging without a formal screening program.

Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni SM, Montazeri A, Momtahen AJ, Kashefi A, Ebrahimi M.

Ann Oncol. 2011 Jan;22(1):93-7. doi: 10.1093/annonc/mdq303. Epub 2010 Jun 9.

PMID:
20534622
28.

Early detection for breast cancer in iran.

Harirchi I, Mousavi SM, Mohagheghi MA, Mousavi-Jarrahi A, Ebrahimi M, Montazeri A, Rahbar MN.

Asian Pac J Cancer Prev. 2009;10(5):849-51.

29.

Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study.

Harirchi I, Karbakhsh M, Montazeri A, Ebrahimi M, Jarvandi S, Zamani N, Momtahen AJ, Kashefi A, Zafarghandi MR.

Eur J Cancer Prev. 2010 Mar;19(2):126-30. doi: 10.1097/CEJ.0b013e328333d0b3.

PMID:
19952761
30.

A multicentre cross-sectional study of arm lymphedema four or more years after breast cancer treatment in Iranian patients.

Haddad P, Farzin M, Amouzegar-Hashemi F, Kalaghchi B, Babazadeh S, Mirzaei HR, Mousavizadeh A, Harirchi I, Rafat J.

Breast Cancer. 2010 Oct;17(4):281-5. doi: 10.1007/s12282-009-0165-1. Epub 2009 Sep 30.

PMID:
19789952
31.

Omission of nasogastric tube application in postoperative care of esophagectomy.

Daryaei P, Vaghef Davari F, Mir M, Harirchi I, Salmasian H.

World J Surg. 2009 Apr;33(4):773-7. doi: 10.1007/s00268-009-9930-8.

PMID:
19219495
32.

Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods.

Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, Ebrahimi M, Haghighat S, Jarvandi S.

Asia Pac Fam Med. 2008 Dec 20;7(1):6. doi: 10.1186/1447-056X-7-6.

33.

Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study.

Montazeri A, Vahdaninia M, Harirchi I, Ebrahimi M, Khaleghi F, Jarvandi S.

BMC Cancer. 2008 Nov 11;8:330. doi: 10.1186/1471-2407-8-330.

34.

Screening for breast cancer in Iran: a challenge for health policy makers.

Mousavi SM, Harirchi I, Ebrahimi M, Mohagheghi MA, Montazeri A, Jarrahi AM, Gouya MM, Miller AB.

Breast J. 2008 Nov-Dec;14(6):605-6. doi: 10.1111/j.1524-4741.2008.00662.x. Epub 2008 Oct 13. No abstract available.

PMID:
19000044
35.

Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study.

Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I.

BMC Cancer. 2008 Sep 30;8:278. doi: 10.1186/1471-2407-8-278.

36.

Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer.

Mahmoodi M, Mir MR, Daryaei P, Harirchi I, Rezaei N, Mohagheghi MA, Mousavi-Jarrahi A, Nahavandian B, Kavianpour M, Jafari A.

Eur Cytokine Netw. 2008 Jun;19(2):92-8. doi: 10.1684/ecn.2008.0126. Epub 2008 Jun 1.

37.

Breast cancer in Iran: an epidemiological review.

Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M.

Breast J. 2007 Jul-Aug;13(4):383-91. Review.

PMID:
17593043
38.

Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.

Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I.

Eur J Cancer Care (Engl). 2007 Mar;16(2):144-9. Review.

PMID:
17371423
39.

Virtual patients in undergraduate surgery education: a randomized controlled study.

Vash JH, Yunesian M, Shariati M, Keshvari A, Harirchi I.

ANZ J Surg. 2007 Jan-Feb;77(1-2):54-9.

PMID:
17295822
40.

Frostbite: incidence and predisposing factors in mountaineers.

Harirchi I, Arvin A, Vash JH, Zafarmand V.

Br J Sports Med. 2005 Dec;39(12):898-901; discussion 901.

41.

Patient delay in women presenting with advanced breast cancer: an Iranian study.

Harirchi I, Ghaemmaghami F, Karbakhsh M, Moghimi R, Mazaherie H.

Public Health. 2005 Oct;119(10):885-91.

PMID:
15913679
42.

Gunshot wound of the heart with embolism to the right axillary artery.

Harirchi I, Salehi M, Ghazisoltani M, Sanatkar-Far M, Satarzadeh R.

Int Surg. 2004 Jul-Sep;89(3):176-80. Review.

PMID:
15521257
43.

Breast cancer in Iran: results of a multi-center study.

Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ.

Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):24-7.

44.

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Yassaee VR, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi MA, Hornby DP, Dalton A.

Breast Cancer Res. 2002;4(4):R6. Epub 2002 Apr 16.

45.

Breast self-examination: knowledge, attitudes, and practices among female health care workers in Tehran, Iran.

Haji-Mahmoodi M, Montazeri A, Jarvandi S, Ebrahimi M, Haghighat S, Harirchi I.

Breast J. 2002 Jul-Aug;8(4):222-5.

PMID:
12100114
46.

Beliefs and behaviours of Iranian teachers toward early detection of breast cancer and breast self-examination.

Jarvandi S, Montazeri A, Harirchi I, Kazemnejad A.

Public Health. 2002 Jul;116(4):245-9.

PMID:
12087485
47.

Anxiety and depression in Iranian breast cancer patients before and after diagnosis.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M.

Eur J Cancer Care (Engl). 2000 Sep;9(3):151-7.

PMID:
11881724
48.

The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M.

Qual Life Res. 2000 Mar;9(2):177-84.

PMID:
10983481
49.

Breast cancer in Iran: a review of 903 case records.

Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A.

Public Health. 2000 Mar;114(2):143-5.

PMID:
10800155
50.

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M.

Support Care Cancer. 1999 Nov;7(6):400-6.

PMID:
10541982

Supplemental Content

Loading ...
Support Center